Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type (2 selected)

Type

Guidance programme (10 selected)

Guidance programme

Showing 701 to 746 of 746

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancerIPG628
Preventing suicide in community and custodial settingsNG105
Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumoursTA539
Leadless cardiac pacemaker implantation for bradyarrhythmiasIPG626
Superior rectal artery embolisation for haemorrhoidsIPG627
Dinutuximab beta for treating neuroblastomaTA538
Sutureless aortic valve replacement for aortic stenosisIPG624
Flu vaccination: increasing uptakeNG103
Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasiaIPG625
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodineTA535
Alectinib for untreated ALK-positive advanced non-small-cell lung cancerTA536
Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDsTA537
Community pharmacies: promoting health and wellbeingNG102
Dupilumab for treating moderate to severe atopic dermatitisTA534
Low-intensity pulsed ultrasound to promote healing of fresh fractures at low risk of non-healingIPG621
Low-intensity pulsed ultrasound to promote healing of fresh fractures at high risk of non-healingIPG622
Low-intensity pulsed ultrasound to promote healing of delayed-union and non-union fracturesIPG623
Ocrelizumab for treating relapsing–remitting multiple sclerosisTA533
Superior capsular augmentation for massive rotator cuff tearsIPG619
Transaxial interbody lumbosacral fusion for severe chronic low back painIPG620
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancerTA531
Crizotinib for treating ROS1-positive advanced non-small-cell lung cancerTA529
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapyTA530
Biomarker tests to help diagnose preterm labour in women with intact membranesDG33
Beta interferons and glatiramer acetate for treating multiple sclerosisTA527
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's diseaseTA217
Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremorIPG617
Laparoscopic ventral mesh rectopexy for internal rectal prolapseIPG618
Dementia: assessment, management and support for people living with dementia and their carersNG97
Guselkumab for treating moderate to severe plaque psoriasisTA521
Midostaurin for untreated acute myeloid leukaemiaTA523
Brentuximab vedotin for treating CD30-positive Hodgkin lymphomaTA524
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapyTA525
Arsenic trioxide for treating acute promyelocytic leukaemiaTA526
Intranasal phototherapy for allergic rhinitisIPG616
Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cancerIPG614
Low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapyIPG615
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapyTA520
Percutaneous balloon valvuloplasty for fetal critical aortic stenosisIPG613
Robot-assisted kidney transplantIPG609
Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasiaIPG611
Microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucomaIPG612
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan IDG32
Nerve transfer to partially restore upper limb function in tetraplegiaIPG610
Tocilizumab for treating giant cell arteritisTA518
Care and support of people growing older with learning disabilitiesNG96

Results per page

  1. 10
  2. 25
  3. 50
  4. All